Back to Trades
Other4
Moderna, Inc.
MRNA
Total Value
$13.3K
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Name
- Mock James M
- Role
- Chief Financial Officer
- Location
- CAMBRIDGE, MA
Officer
Filing Details
- Filing Date
- Dec 1, 2025
- Transaction Date
- Nov 26, 2025
- Accession Number
- 0001682852-25-000082
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 26, 2025 | Common Stock | 773 | — | Exercise | — |
| Nov 26, 2025 | Common Stock | 374 | $24.75 | Tax Withholding | $9.3K |
| Nov 28, 2025 | Common Stock | 329 | — | Exercise | — |
| Nov 28, 2025 | Common Stock | 160 | $25.01 | Tax Withholding | $4.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Nov 26, 2025 | Derivative | 773 | — | Exercise | — |
| Nov 28, 2025 | Derivative | 329 | — | Exercise | — |
Footnotes
- (F1)Restricted stock units convert into common stock on a one-for-one basis.
- (F2)Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- (F3)25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- (F4)25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.